e-learning
resources
Munich 2006
Wednesday 06.09.2006
Immunology of tuberculosis and diagnosis of tuberculosis infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of antituberculosis treatment on interferon- γ responses to ESAT-6 and CFP-10
M. Bugiani, M. P. Forneris, L. Fabbro, P. Piccioni, M. Cavallero, A. Mondo, C. Preziosi, S. Bonora (Turin, Italy)
Source:
Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Session:
Immunology of tuberculosis and diagnosis of tuberculosis infection
Session type:
Oral Presentation
Number:
4638
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bugiani, M. P. Forneris, L. Fabbro, P. Piccioni, M. Cavallero, A. Mondo, C. Preziosi, S. Bonora (Turin, Italy). The effect of antituberculosis treatment on interferon- γ responses to ESAT-6 and CFP-10. Eur Respir J 2006; 28: Suppl. 50, 4638
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Comparison of ELISPOT and whole-blood assays for IFN-gamma in the immune diagnosis of tuberculosis using ESAT-6 and CFP-10 selected peptides
Source: Eur Respir J 2004; 24: Suppl. 48, 206s
Year: 2004
IGG immune response against MPT-64, CFP-10 and ESAT-6 antigens in children with pulmonary tuberculosis
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009
Dynamic changes of Th1-cell immune response to ESAT-6 and CFP-10 during anti-tuberculosis treatment
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals, and controls with the TB antigens ESAT-6, CFP-10, and TB7.7
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
ESAT-6/CFP-10 and PPD-stimulated cytokine production in patients with MTB infection
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Year: 2007
Effect of isoniazid on antigen-specific interferon-? secretion in latent tuberculosis
Source: Eur Respir J 2015; 45: 473-482
Year: 2015
Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens
Source: Eur Respir J 2010; 36: 355
Year: 2010
A new immune diagnostic assay based on ESAT-6 and CFP-10 epitopes in the evaluation of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 427s
Year: 2004
Effect of prophylaxis on responses for ESAT-6/CFP-10 in whole blood IFN-g test
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005
Screening for latent TB using antigen-specific IP-10 response and the effect of prednisolon
Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2012
Quantitative T-cell interferon-gamma responses to
Mycobacterium tuberculosis
-specific antigens in latent and active tuberculosis
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008
Changes of ESAT-6/CFP-10 – stimulated IFN-g and IL-2 production during specific anti-tuberculosis treatment in children
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009
Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to
M. tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 363s
Year: 2006
Interferon-gamma responses and the spectrum of tuberculosis
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Response to Mtb Rv2628 latency antigen associates with bacterial containment
Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2012
Tuberculosis-specific T-cell response after recent treatment and remote cure
Source: Eur Respir J 2011; 38: 1225-1228
Year: 2011
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy
Source: Eur Respir J 2007; 30: 1173-1179
Year: 2007
Effect of isoniazid prophylaxis for latent TB on interferon-gamma response
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Pre-clinical study of specific activity and specificity of recombinant diagnostic preparation DIASKINTEST based on proteins ESAT-6 and CFP10 in guinea-pigs infected with
M. tuberculosis
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010
Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of
mycobacterium tuberculosis
infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept